MedPath

clinical trial comparing the long term outcomes of post discharge probiotic treatment in moderately premature infants

Phase 3
Registration Number
CTRI/2017/12/011033
Lead Sponsor
Surya Childrens Medicare Pvt Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Other (Terminated)
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All preterm NICU graduates born less than 33 weeks of gestation will be randomised to the two study groups at 3 weeks post discharge

The 3 week cutoff is because these infants routinely receive probiotics during NICU stay. A wash out period of 3 weeks might be need to rule out continued effects of initial probiotic supplementation in the placebo group.

Exclusion Criteria

Parental refusal for consent and families living out of Mumbai

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath